The COVID-19 Crisis and Supportive Role of Pharmacists in Cancer Patients
DOI:
https://doi.org/10.36570/jduhs.2020.2.966Abstract
The novel viral disease (COVID-19) with pneumonia like symptoms was first detected in Wuhan City of China, later reaching a status of the pandemic. The corona virus is now found affecting people all across the globe that in turn, threatens a great majority of people, both healthy and diseased. In particular, the population of patient is at high risk of being inflicted with infection.
Downloads
References
doi.org/10.1016/j.annonc.2020.03.296
2. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med 2020; 172:756-8. doi.org/10.7326/M20-1133
3. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21:e181.
doi.org/10.1016/S1470-2045(20)30149-2
4. Sheppard J, Thomas CB. Community pharmacists and communication in the time of COVID-19: applying the health belief model. Res Social Adm Pharm 2020; S1551-7411(20)30293-X.
doi.org/10.1016/j.sapharm.2020.03.017
5. Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: On the frontline of health service against COVID-19. Res Social Adm Pharm 2020; S1551-7411(20)30328-4.
doi.org/10.1016/j.sapharm.2020.04.013
6. Liekweg A, Westfeld M, Jaehde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12:73-9.
doi.org/10.1007/s00520-003-0539-4
7. Leveque D, Delpeuch A, Gourieux B. New anticancer agents: role of clinical pharmacy services. Anticancer Res 2014; 34:1573-8.
8. Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Social Adm Pharm 2020; S1551-7411(20)30284-9. doi.org/10.1016/j.sapharm.2020.03.012
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Mayyda Asif Bajwa, Dr, Kanwal Ashiq, Dr
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal.